Papers
12
Total Citations
242
H-Index
8
About
Adam Calaway is a urologic surgeon and researcher whose work centers on advancing robotic-assisted surgical techniques for prostate and kidney cancers, with a particular focus on optimizing patient outcomes and minimizing complications. His major contributions include defining best practices for extended pelvic lymphadenectomy in high-risk prostate cancer patients, where his landmark 2012 study (73 citations) established critical benchmarks for nodal yield. He has also pioneered research on the safety and efficacy of robotic retroperitoneal lymph node dissection for testicular cancer (64 citations), challenging traditional open surgical approaches. Calaway’s work consistently addresses real-world clinical challenges, such as the impact of obesity on wound complications—showing that robotic techniques mitigate risks compared to open surgery—and the effects of prior prostate procedures on subsequent robotic prostatectomy outcomes. His innovative spirit extends to patient-centered care, as demonstrated by a randomized controlled trial (11 citations) showing that music therapy reduces postoperative pain and anxiety after robotic prostatectomy. With over 230 total citations across his most-cited papers, Calaway’s research has shaped modern urologic oncology, emphasizing surgical quality improvement, functional preservation, and evidence-based perioperative care.
Research Focus
Key Achievements
Top Papers
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8Robotic Partial Nephrectomy8 citations · 2020
- 9
- 10